Top Companies in Digital Pathology Market | Leading Players Size, Share, Future and Past data by VMR

The Digital Pathology market is witnessing growth due to the factors such as growth in the incidences of cancer, growth in the adoption of Digital Pathology to increase lab efficiency, and increasing applications of Digital Pathology in companion diagnostics and drug development.

Top Companies in Digital Pathology Market | Leading Players Size, Share, Future and Past data by VMR
digital pathology market

Upcoming Trends in Digital Pathology Market  

Digital Pathology Market was valued at USD 732.1 Million in 2021 and is projected to reach a value of USD 1516.1 Million by 2028 at a CAGR of 12.9% over the forecast period. The increasing trend of digitalization in the healthcare industry is expected to boom the market. The need for faster results and accurate testing methods can be provided by a digital pathology system.  

Instead of conventional microscopy, a pathologist will perform a diagnosis by interacting with images on computer screens and performing quantitative analysis. The fourth generation of virtual slide telepathology systems, so-called virtual microscopy and whole-slide imaging (WSI), has allowed for the storage and fast dissemination of image data in pathology and other biomedical areas. These novel digital imaging modalities encompass high-resolution scanning of tissue slides and derived technologies, including automatic digitization and the computational processing of whole microscopic slides.

Therefore, the challenge is to apply information technology and image analysis methods to exploit the new and emerging digital pathology technologies effectively in order to process and model all the data and information contained in WSI.

Some of the key players operating in the digital pathology market are listed below:

Company Name

Revenue in USD

  • Leica Biosystems

$814 Million

  • Koninklijke Philips N.V.

$19 Billion

  • Hamamatsu Photonics

$1 Billion

  • F. Hoffmann-La Roche Ltd.

$71 Billion


$21 Million

  • Apollo Enterprise Imaging

<$5 Million

  • XIFIN, Inc.

$259 Million

  • Huron Digital Pathology

<$5 Million

  • Visiopharm A/S

$16 Million

  • Aiforia Technologies Oy

<$5 Million


  1. Leica Biosystems

The company has headquarters in Germany with operations in the United Kingdom, Ireland, Netherlands, Bulgaria, Australia, India, China, Singapore, Mexico, and the United States (California, Illinois, Massachusetts, and Ohio). A research and development facility concentrating on companion diagnostics for cancer drugs has been in operation in Danvers, Massachusetts since August 2012. The Massachusetts facility has partnered with Galena Biopharma to develop companion diagnostics for a breast cancer vaccine. Leica Biosystems acquired Aperio, an ePathology solutions company, in October 2012. For instance, in October 2014, the company announced it will purchase Devicor Medical Products, which is headquartered in Cincinnati and makes medical devices used in breast biopsies. The company was founded in 1939 and headquartered in Wetzlar, Germany.

  1. Koninklijke Philips N.V.

Koninklijke Philips N.V. is a Dutch multinational conglomerate corporation that was founded in Eindhoven in 1891. Since 1997, it has been mostly headquartered in Amsterdam, though the Benelux headquarters is still in Eindhoven. The company is listed in the stock exchange market as PHIA (AMS). The company has 81,592 currently working and generated USD 195.3 billion in 2020.

  1. Hamamatsu Photonics

Hamamatsu Photonics K.K. is a Japanese manufacturer of optical sensors, electric light sources, and other optical devices and their applied instruments for scientific, technical, and medical use. The company is listed as 6965 (TYO) in the Japanese stock market. The company was founded in 1953 and is headquartered in Tokyo. The company has 4,420 employees currently working. 

  1. Hoffmann-La Roche Ltd.

Hoffmann-La Roche AG, commonly known as Roche, is a Swiss multinational healthcare company that operates worldwide under two divisions: Pharmaceuticals and Diagnostics. Its holding company, Roche Holding AG, has shares listed on the Swiss Exchange. The company headquarters are located in Basel. The company is listed in the Swiss stock market as ROG (SWX) and generated revenue of USD 62.42 billion.


3DHISTECH is dedicated to providing clinical pathologists, researchers, and universities with digital pathology solutions to facilitate quick and accurate diagnostics, support medical discoveries, and foster education. The company is a privately held organization.   

  1. Apollo Enterprise Imaging

The company is a privately held organization founded in 2006. Apollo Enterprise Imaging – offering healthcare’s most mature and advanced, clinical content management and interoperability solution, used by health systems across North America. The company is an amazing team of experts in healthcare Enterprise imaging, workflows, and clinical system interoperability. Enterprise Imaging solution is built on the industry’s first clinical convergence solution stack technology.

  1. XIFIN, Inc.

XIFIN is a health information technology company that leverages diagnostic information to improve the quality and economics of healthcare.

  1. Huron Digital Pathology

Huron Digital Pathology is on a mission to connect pathologists to the vast knowledge contained in the world's pathology reports. Scan, Index, and Search platform for pathology combines award-winning whole slide imaging hardware with powerful image search technology to connect pathologists and researchers with the expertise of their colleagues to help speed up diagnosis and accelerate disease research.

  1. Visiopharm A/S

Visiopharm’s pioneering image analysis tools support thousands of scientists, pathologists, and image analysis experts in both academic institutions and the biopharmaceutical industry. AI-based image analysis and tissue mining tools support research and drug development research worldwide, while their CE-IVD APPs support primary diagnostics. With the most advanced and sophisticated artificial intelligence and deep learning, they deliver tissue data mining tools, precision results, and workflows.

  1. Aiforia Technologies Oy

Aiforia equips pathologists and scientists in preclinical and clinical labs with powerful deep learning artificial intelligence software for translating images into discoveries, decisions, and diagnoses. The cloud-based Aiforia products and services aim to escalate the efficiency and precision of medical image analysis beyond current capabilities, across a variety of fields from oncology to neuroscience and more.

Get a Free Sample Here:

For More Information about each of these companies.
Vantage Market Research Report comes up with a detailed analysis of each major player in the industry. The Study provides Global market size & share, Emerging trends, an in-depth analysis of key players, Development opportunities, Sales, and a Revenue Forecast.